Day One Shrinks Brain Tumors for Kids, Gears Up for First-Line Study

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more.


You may also like

Better Cancer Drugs for Kids: Julie Grant and Sam Blackman on The Long Run
No Longer an Afterthought: Day One Raises $130M for Childhood Cancer Therapies
Day One, Taking a Page from Rare Disease Playbook, Raises $60M for Kids With Cancer